Noile-Immune Biotech, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-962.00
-1,127.00
-384.00
-792.00
-630.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
76.00
-95.00
0.00
-9.00
134.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-887.00
-873.00
-107.00
-777.00
-300.00
Cash Flow from Investing Activities
0.00
-5.00
0.00
-4.00
0.00
Cash Flow from Financing Activities
2.00
1,913.00
487.00
2,373.00
996.00
Net Cash Inflow / Outflow
-884.00
1,034.00
380.00
1,592.00
695.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Noile-Immune Biotech, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-962.035
4368.056
-5,330.00
-122.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
76.674
151.804
-75.00
-49.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-887.809
3830.664
-4,717.00
-123.18%
Cash Flow from Investing Activities
0.557
-1471.124
1,471.00
100.04%
Cash Flow from Financing Activities
2.5
795.246
-793.00
-99.69%
Net Cash Inflow / Outflow
-884.752
3159.868
-4,043.00
-128.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
5.082
-5.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -1.69% vs -714.62% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-887.81
-873.08
-1.69%






